Research Overview
Position in NAD+ metabolism
Mammalian cells maintain NAD+ largely through salvage rather than de novo synthesis. Nicotinamide riboside enters that network one step below nicotinamide, bypassing nicotinamide phosphoribosyltransferase entirely, which is the property that makes it useful experimentally. Comparative studies place it alongside NMN, nicotinamide and nicotinic acid to ask which precursor raises tissue NAD+ most efficiently and in which organs.
Enzymes that consume NAD+
- Sirtuins SIRT1 to SIRT7, which use NAD+ as a co-substrate for deacylation reactions
- PARP enzymes, whose activation during DNA damage response draws heavily on the NAD+ pool
- CD38 and CD157, NAD+ glycohydrolases whose activity rises in aged tissue in reported models
Tracer and analytical work
Isotope-labelled nicotinamide riboside has been central to sorting out what actually happens after oral exposure. Labelling studies have shown that a large fraction is cleaved to nicotinamide before reaching peripheral tissue, so distinguishing intact nucleoside uptake from indirect delivery is a live methodological question. Quantitation is usually by LC-MS/MS, since NR, NMN and nicotinamide must be resolved from one another.
Stability considerations
The free base is unstable; the chloride salt is the practical solid form and remains the subject of formulation research, particularly around hygroscopicity, thermal degradation and behaviour at neutral to alkaline pH where the glycosidic bond is more labile.
